Low-dose hypersensitivity after fractionated low-dose irradiation in vitro
- PMID: 11403705
- DOI: 10.1080/09553000110041326
Low-dose hypersensitivity after fractionated low-dose irradiation in vitro
Abstract
Purpose: It was demonstrated previously that some radioresistant tumour cell lines respond to decreasing single, low radiation doses by becoming increasingly radiosensitive. This paper reports the response of four radioresistant human glioma cell lines to multiple low-dose radiation exposures given at various intervals. Three of the cell lines (T98G, U87, A7) were proven already to show low-dose hyper-radiosensitivity (HRS) after single low doses; the fourth, U373, does not show HRS after acute doses.
Materials and methods: Clonogenic cell-survival measurements were made in vitro using the Dynamic Microscopic Image Processing Scanner (DMIPS) or Cell Sorter (CS) following exposure to 240kVp X-rays one or more times.
Results: A consistent, time-dependent hypersensitive response to a second, or subsequent, dose was observed in the cell lines that demonstrated HRS. This time-dependent change in radiosensitivity did not occur in the radioresistant cell line that did not show HRS (U373). In one cell line that demonstrated strong HRS, T98G, a similar time-dependent hypersensitive response was also seen when the cells were irradiated whilst held in the G1-phase of the cell cycle. In this same cell line, significantly increased cell kill was demonstrated when three very low doses (0.4 Gy) were given per day, 4 h apart, for 5 days, compared with the same total dose given as once-daily 1.2Gy fractions.
Conclusions: These data demonstrate the possibility that a multipledose per day, low-dose per fraction regimen, termed 'ultrafractionation', could produce increased tumour cell kill in radioresistant tumours compared with the same total dose given as conventional-sized 2 Gy fractions.
Similar articles
-
Effect of subsequent acute-dose irradiation on cell survival in vitro following low dose-rate exposures.Int J Radiat Biol. 2002 Nov;78(11):981-90. doi: 10.1080/0955300021006589. Int J Radiat Biol. 2002. PMID: 12456285
-
Effects of cell cycle phase on low-dose hyper-radiosensitivity.Int J Radiat Biol. 2003 Feb;79(2):99-105. Int J Radiat Biol. 2003. PMID: 12569013
-
Low-dose hyperradiosensitivity of human glioblastoma cell lines in vitro does not translate into improved outcome of ultrafractionated radiotherapy in vivo.Int J Radiat Biol. 2005 Oct;81(10):751-8. doi: 10.1080/09553000500491537. Int J Radiat Biol. 2005. PMID: 16449082
-
Overview of radiosensitivity of human tumor cells to low-dose-rate irradiation.Int J Radiat Oncol Biol Phys. 2008 Nov 1;72(3):909-17. doi: 10.1016/j.ijrobp.2008.06.1928. Int J Radiat Oncol Biol Phys. 2008. PMID: 19014780 Review.
-
Radiosensitivity of human cell lines to small doses. Are there some clinical implications?Radiat Res. 1994 Apr;138(1 Suppl):S25-7. Radiat Res. 1994. PMID: 8146319 Review.
Cited by
-
Optimization strategies for pulsed low-dose-rate IMRT of recurrent lung and head and neck cancers.J Appl Clin Med Phys. 2014 May 8;15(3):4661. doi: 10.1120/jacmp.v15i3.4661. J Appl Clin Med Phys. 2014. PMID: 24892337 Free PMC article.
-
Low-dose fractionated radiotherapy and concomitant chemotherapy for recurrent or progressive glioblastoma: final report of a pilot study.Strahlenther Onkol. 2014 Apr;190(4):370-6. doi: 10.1007/s00066-013-0506-z. Epub 2014 Jan 17. Strahlenther Onkol. 2014. PMID: 24429479 Clinical Trial.
-
Pulsed low dose-rate irradiation response in isogenic HNSCC cell lines with different radiosensitivity.Radiol Oncol. 2020 Mar 27;54(2):168-179. doi: 10.2478/raon-2020-0015. Radiol Oncol. 2020. PMID: 32229678 Free PMC article.
-
Impact of time interval and dose rate on cell survival following low-dose fractionated exposures.J Radiat Res. 2017 Nov 1;58(6):782-790. doi: 10.1093/jrr/rrx025. J Radiat Res. 2017. PMID: 28595296 Free PMC article.
-
Identification of low-dose radiation-induced exosomal circ-METRN and miR-4709-3p/GRB14/PDGFRα pathway as a key regulatory mechanism in Glioblastoma progression and radioresistance: Functional validation and clinical theranostic significance.Int J Biol Sci. 2021 Mar 2;17(4):1061-1078. doi: 10.7150/ijbs.57168. eCollection 2021. Int J Biol Sci. 2021. PMID: 33867829 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources